Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Odonate Therapeutics, Inc. | 77,331 | reported | 19 Sept 2019 | tx 6+176,291−154,206 |
| SPECTRUM PHARMACEUTICALS INC | 50,000 | reported | 03 Jan 2011 | tx 6+291,125 |
| ANAVEX LIFE SCIENCES CORP. | 8,000 | reported | 09 Feb 2012 | tx 2+12,000 |
| REVELATION BIOSCIENCES, INC. | 268 | reported | 11 Feb 2025 | tx 19+211,037−67,502 |
| LA JOLLA PHARMACEUTICAL CO | 2 | reported | 15 Apr 2019 | tx 72+960,710,872−506,468,829 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2025 | GRANT_AWARD | REVELATION BIOSCIENCES, INC. | 181 | 3.87 USD | |
| 08 Dec 2023 | SALE | REVELATION BIOSCIENCES, INC. | 27,771 | 0.52 USD | |
| 16 Oct 2023 | SALE | REVELATION BIOSCIENCES, INC. | 1,845 | 0.65 USD | |
| 16 Oct 2023 | SALE | REVELATION BIOSCIENCES, INC. | 10,957 | 0.66 USD | |
| 28 Sept 2023 | SALE | REVELATION BIOSCIENCES, INC. | 1,429 | 0.69 USD | |
| 15 Sept 2023 | SALE | REVELATION BIOSCIENCES, INC. | 9,500 | 0.73 USD | |
| 14 Sept 2023 | SALE | REVELATION BIOSCIENCES, INC. | 12,000 | 0.75 USD | |
| 18 Sept 2023 | SALE | REVELATION BIOSCIENCES, INC. | 4,000 | 0.74 USD | |
| 18 Apr 2023 | PURCHASE | REVELATION BIOSCIENCES, INC. | 25,000 | 1.16 USD | |
| 17 Apr 2023 | PURCHASE | REVELATION BIOSCIENCES, INC. | 26,500 | 1.16 USD | first after silence |
| 14 Apr 2023 | GRANT_AWARD | REVELATION BIOSCIENCES, INC. | 6,356 | 0.00 USD | deriv |
| 25 Feb 2022 | PURCHASE | REVELATION BIOSCIENCES, INC. | 20,000 | 1.60 USD | |
| 08 Feb 2022 | PURCHASE | REVELATION BIOSCIENCES, INC. | 1,000 | 2.54 USD | |
| 09 Feb 2022 | PURCHASE | REVELATION BIOSCIENCES, INC. | 30,000 | 2.55 USD | |
| 07 Feb 2022 | PURCHASE | REVELATION BIOSCIENCES, INC. | 42,100 | 2.61 USD | |
| 04 Feb 2022 | PURCHASE | REVELATION BIOSCIENCES, INC. | 7,900 | 2.31 USD | |
| 19 Sept 2019 | EXERCISE | Odonate Therapeutics, Inc. | 77,331 | 0.00 USD | |
| 19 Sept 2019 | EXERCISE | Odonate Therapeutics, Inc. | 73,960 | 0.00 USD | |
| 19 Sept 2019 | EXERCISE | Odonate Therapeutics, Inc. | 75,385 | 0.00 USD | deriv |
| 19 Sept 2019 | EXERCISE | Odonate Therapeutics, Inc. | 78,821 | 0.00 USD | deriv |
| 15 Apr 2019 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 2 | 6.09 USD | |
| 15 Apr 2019 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 2 | 0.00 USD | deriv |
| 29 Mar 2019 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 94 | 5.47 USD | |
| 29 Mar 2019 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 94 | 0.00 USD | deriv |
| 15 Mar 2019 | GRANT_AWARD | LA JOLLA PHARMACEUTICAL CO | 195 | 6.49 USD |
4 purchases reported after at least 12 months of silence — most recent on 17 Apr 2023.